Decibel Therapeutics, Inc. financial data

Industry
Pharmaceutical Preparations
Location
1325 Boylston Street, Suite 500, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2023 - Aug 11, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 430 % -44.7%
Debt-to-equity 55.9 % +80.5%
Return On Equity -84 % -86.5%
Return On Assets -53.9 % -56.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.1M shares +0.65%
Common Stock, Shares, Outstanding 25.1M shares +0.67%
Entity Public Float 70.8M USD -47.1%
Common Stock, Value, Issued 25K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25M shares +0.24%
Weighted Average Number of Shares Outstanding, Diluted 25M shares +0.24%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 42.4M USD +18.7%
General and Administrative Expense 23.6M USD +2.59%
Operating Income (Loss) -66M USD -12.4%
Nonoperating Income (Expense) 2.89M USD +1033%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -63.1M USD -7.94%
Income Tax Expense (Benefit) 283K USD -85.1%
Net Income (Loss) Attributable to Parent -63.4M USD -5.02%
Earnings Per Share, Basic -2.54 USD/shares -7.35%
Earnings Per Share, Diluted -2.54 USD/shares -7.35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 39.8M USD -29.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 80.4M USD -43.1%
Property, Plant and Equipment, Net 3.96M USD -18.6%
Operating Lease, Right-of-Use Asset 8.95M USD -16.4%
Other Assets, Noncurrent 934K USD -19.8%
Assets 94.4M USD -40.4%
Accounts Payable, Current 617K USD -67.8%
Employee-related Liabilities, Current 2.1M USD
Liabilities, Current 26.6M USD +16.2%
Operating Lease, Liability, Noncurrent 9.14M USD -22.1%
Other Liabilities, Noncurrent 1.91M USD +18.5%
Liabilities 41.1M USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -35K USD +94%
Retained Earnings (Accumulated Deficit) -309M USD -25.8%
Stockholders' Equity Attributable to Parent 53.3M USD -52.3%
Liabilities and Equity 94.4M USD -40.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.1M USD +22.5%
Net Cash Provided by (Used in) Financing Activities 197K USD
Net Cash Provided by (Used in) Investing Activities 20.3M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 25.1M shares +0.65%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.46M USD
Deferred Tax Assets, Valuation Allowance 74.9M USD +31.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure 0%
Deferred Tax Assets, Gross 78.1M USD +35.2%
Operating Lease, Liability 12.8M USD -16.4%
Depreciation 340K USD -7.36%
Payments to Acquire Property, Plant, and Equipment 266K USD +163%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -62.8M USD -3.09%
Lessee, Operating Lease, Liability, to be Paid 14.9M USD -19.7%
Property, Plant and Equipment, Gross 11.7M USD +0.92%
Operating Lease, Liability, Current 3.61M USD +2.53%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.89M USD +2.45%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.8M USD +2.46%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.14M USD -35.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.98M USD +2.44%
Deferred Tax Assets, Operating Loss Carryforwards 59.1M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.63M USD -21.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.35M USD -66.1%
Operating Lease, Payments 915K USD +2.24%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.2M USD +314%
Share-based Payment Arrangement, Expense 3.86M USD +24.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%